- Sanofi (NASDAQ:SNY) is scheduled to announce Q2 earnings results on Thursday, July 29th, before market open.
- The consensus EPS Estimate is €1.32 (+3.1% Y/Y) and the consensus Revenue Estimate is €8.38B (+2.1% Y/Y).
- Over the last 1 year, SNY has beaten EPS estimates 100% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. Revenue estimates have seen 1 upward revision and 4 downward.
- Recently, Sanofi agreed to sell eight products commercialized in Latin America to HYPERA as part of its efforts to streamline its consumer healthcare portfolio.
- Seeking Alpha contributor Gio Danisi said that Sanofi's reorganization needs to be faster, and argued that the "company should pivot its focus on its strengths by restructuring or spinning-off the rest, in order to meet its strategic targets".
- Sanofi had reported Q1 results that beat estimates for both revenue and profit, helped by the performance of its Dupixent business, on April 28.
- The company's shares have gained more than 6% in value year to date.